Search clinical trials for: RAG-17

Total 2911 results

Beijing Tiantan Hospital
Ractigen Therapeutics

Enrolling by invitation

Safety and Tolerability of RAG-17 in the Treatment of Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation

Gene Mutation

China
National Cancer Institute (NCI)

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Unspecified Childhood Solid Tumor, Protocol Specific | Secondary Acute Myeloid Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Acute Undifferentiated Leukemia

United States
National Cancer Institute (NCI)

Completed

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Recurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Thyroid Gland Medullary Carcinoma

United States
National Cancer Institute (NCI)

Completed

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma

United States
National Cancer Institute (NCI)

Terminated

Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer

Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
wei bo

Unknown

Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted Gastrectomy

Gastric Cancer
National Cancer Institute (NCI)

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
National Cancer Institute (NCI)

Terminated

Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
Biogen

Terminated

Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL

Chronic Lymphocytic Leukemia

United States
National Cancer Institute (NCI)

Terminated

Tanespimycin in Treating Patients With Stage III-IV Melanoma

Recurrent Melanoma | Stage IV Melanoma | Stage III Melanoma

United States
National Cancer Institute (NCI)

Completed

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Kidney Cancer | Hippel-Lindau Disease

United States
National Cancer Institute (NCI)

Terminated

17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent... and other conditions

United States
VA Office of Research and Development

Completed

Rage Against the Pain (RAP)

Chronic Low Back Pain

United States
Celgene

Withdrawn

A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Solid Tumor

United States
National Cancer Institute (NCI)

Completed

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

Childhood Chronic Myelogenous Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Recurrent Neuroblastoma | Recurrent Osteosarcoma | Recurrent Childhood Rhabdomyosarcoma | Metastatic Osteosarcoma | Disseminated Neuroblastoma | Previously Treated... and other conditions

United States
National Cancer Institute (NCI)

Terminated

Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
National Cancer Institute (NCI)

Completed

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer

Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer

United States
Ramos Mejía Hospital

Completed

Mechanical Power and Ventilatory Ratio in ARDS

Acute Respiratory Distress Syndrome

Argentina
Bio-Rad Laboratories
Centers for Disease Control and Prevention; American National Red Cross

Completed

Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol

Mass Screening

United States, Puerto Rico
National Cancer Institute (NCI)

Active, not recruiting

Screening for Lung Cancer in Older Patients (PLCO Screening Trial)

Lung Carcinoma

United States
Hannover Medical School

Unknown

Northern Survey on Therapeutic Oxygen Prescription (NONSTOP)

Oxygen Toxicity

Germany
Wake Forest University

Completed

Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis

Atopic Dermatitis

United States
National Cancer Institute (NCI)

Completed

Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Recurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma

United States
Ractigen Therapeutics.

Recruiting

A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

Non-Muscle-Invasive Bladder Cancer (NMIBC)

Australia
Sohag University

Not yet recruiting

IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage

Systemic Lupus Erythematosus

Egypt
Mesoestetic Pharma Group S.L.

Completed

Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy

Facial Rejuvenation

Bulgaria
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Recurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage IV Prostate Cancer

United States
Assiut University

Not yet recruiting

Role of Serum ADAM 17 (A Disintegrin And Metalloprotease 17) and Caspase 3 in Patients With Chronic Kidney Disease

Chronic Kidney Diseases
Centre Hospitalier Universitaire Dijon

Recruiting

DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls (DepLIPIDO)

Depression

France
Medibio Limited

Completed

Medibio DDA Confirmatory Performance Study

Major Depressive Episode

United States, Australia
Aswan University Hospital

Unknown

17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa

Placenta Previa

Egypt
Steve N. Caritis, MD
AMAG Pharmaceuticals, Inc.

Terminated

17-OHPC in Pregnancy: IM vs SC Routes

Preterm Birth

United States
National Cancer Institute (NCI)

Terminated

PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
University of Helsinki
Päivikki and Sakari Sohlberg Foundation, Finland; Finnish Medical Foundation; Emil Aaltonen Foundation

Completed

Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT) (SYMPTOM)

Cardiovascular Disease | Postmenopausal Vasomotor Symptoms

Finland
University of Pittsburgh
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Study of Pharmacology of 17-OHPC in Pregnancy

Pregnancy

United States
Mesoestetic Pharma Group S.L.
Opera CRO, a TIGERMED Group Company

Completed

Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation

Facial Rejuvenation

Romania
First Affiliated Hospital of Chongqing Medical...

Completed

Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression

Major Depressive Disorder | Psychiatric Disorder | Metabolic Disorder

China
University of Luebeck

Completed

Randomized Clinical Trial on Follicular Flushing in IVF

Infertility

Germany
Universidad El Bosque, Bogotá
Gloria Lafaurie; Carlos Leal

Completed

Horizontal Ridge Augmentation in Mandible Usign ROG + ESWT

Bone Regeneration

Colombia
National Cancer Institute (NCI)

Completed

17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Terminated

17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia

United States
Babbette Lamarca

Recruiting

Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia (PROGRESS)

Pregnancy

United States
Cancer Institute and Hospital, Chinese Academy...
Beijing Chaoyang District Centre for Disease Control and Prevention; Neimenggu...

Unknown

The Phase IVa of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17)

Safety of Inactivated EV71 Vaccine | Immunization of Inactivated EV71 Vaccine

China
Cathay General Hospital
Chang Gung Memorial Hospital; Cheng-Hsin General Hospital; Chang Gung University and other collaborators

Unknown

Effects of Robot-Assisted Combined Therapy in Upper Limb Rehabilitation in Stroke Patients

Cerebrovascular Accident

Taiwan
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed

Determination of Glycemic Index and Glycemic Load of Cereal Fiber Powder

Glycemic Index

China
National Cancer Institute (NCI)

Completed

17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor

Unspecified Adult Solid Tumor, Protocol Specific

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas

Pelvic Sarcoma

United States
Beijing Jishuitan Hospital

Enrolling by invitation

Does Medial Raw Anchor Necessary During Tendon Repair Combined With Microfracture

Full Rotator Cuff Tear | Microfracture Procedure | Double Raw Repair | Lateral Raw Repair

China
Vanderbilt University Medical Center
American Heart Association

Not yet recruiting

Long COVID Immune Profiling

Long COVID | Autonomic Dysfunction | POTS - Postural Orthostatic Tachycardia Syndrome
Oswaldo Cruz Foundation

Recruiting

Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals (YF-HIV)

HIV Infections

Brazil

Search clinical trials for: RAG-17

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations